| Bid Price | 304.50p | High Price | 319.50p |
|---|
| Ask Price | 307.50p | Low Price | 300.00p |
|---|
| Open Price | 303.50p | Spread | 0.98% |
|---|
| Prev Close | 307.50p | Volume | 151,248 |
|---|
Oxford Biomedica PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Mar 21, 2025 | 303.50 | 319.50 | 300.00 | 304.50 | 151,248 |
| Mar 20, 2025 | 314.50 | 314.50 | 302.50 | 307.50 | 65,506 |
| Mar 19, 2025 | 291.00 | 313.50 | 291.00 | 306.00 | 135,236 |
| Mar 18, 2025 | 296.50 | 306.50 | 291.50 | 306.00 | 320,179 |
| Mar 17, 2025 | 290.00 | 297.00 | 280.30 | 293.00 | 114,151 |
Oxford Biomedica PLC Information
| Name | Oxford Biomedica PLC | Index | FTSE All Share |
|---|
| ISIN | GB00BDFBVT43 | Epic | OXB |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SSMM |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 3,000 | Trading Status | Closed |
|---|
| Shares in Issue | 105.97 m | Prev Close | 307.50p |
|---|
| PE Ratio | 20.618557 | Market Cap | £322.69 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.31 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.16645 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.347935 | Quick Ratio | 1.835348 |
|---|
Oxford Biomedica PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 16/11/23 | BUY | Michael Hayden | RES | 10,000 @ £1.93 | £19,281.00 |
| 14/11/23 | BUY | Michael Hayden | RES | 10,000 @ £1.93 | £19,281.00 |
| 11/10/23 | BUY | Namrata Patel | NED | 1,670 @ £2.99 | £4,993.00 |
| 27/09/23 | BUY | Michael Hayden | RES | 12,000 @ £2.94 | £35,220.00 |
| 26/09/23 | BUY | Leone Patterson | RES | 6,598 @ £2.91 | £19,167.00 |
| 26/09/23 | BUY | Dame Davies | NED | 1,000 @ £2.91 | £2,910.00 |
| 20/09/23 | BUY | Stuart Paynter | RES | 4,030 @ £2.48 | £9,998.00 |
| 20/09/23 | BUY | Stuart Henderson | NED | 1,000 @ £2.75 | £2,750.00 |
| 20/09/23 | BUY | Roch Doliveux | CH | 36,130 @ £2.74 | £99,105.00 |
| 20/09/23 | BUY | Catherine Moukheibir | RES | 7,226 @ £2.74 | £19,821.00 |
Oxford Biomedica PLC News
